Correlation Between Intracellular and Esperion Therapeutics
Can any of the company-specific risk be diversified away by investing in both Intracellular and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intracellular and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intracellular Th and Esperion Therapeutics, you can compare the effects of market volatilities on Intracellular and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intracellular with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intracellular and Esperion Therapeutics.
Diversification Opportunities for Intracellular and Esperion Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Intracellular and Esperion is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Intracellular Th and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Intracellular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intracellular Th are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Intracellular i.e., Intracellular and Esperion Therapeutics go up and down completely randomly.
Pair Corralation between Intracellular and Esperion Therapeutics
Given the investment horizon of 90 days Intracellular is expected to generate 12.29 times less return on investment than Esperion Therapeutics. But when comparing it to its historical volatility, Intracellular Th is 2.78 times less risky than Esperion Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 213.00 in Esperion Therapeutics on August 31, 2024 and sell it today you would earn a total of 41.00 from holding Esperion Therapeutics or generate 19.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intracellular Th vs. Esperion Therapeutics
Performance |
| Timeline |
| Intracellular Th |
| Esperion Therapeutics |
Intracellular and Esperion Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intracellular and Esperion Therapeutics
The main advantage of trading using opposite Intracellular and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intracellular position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.| Intracellular vs. Alkermes Plc | Intracellular vs. Ironwood Pharmaceuticals | Intracellular vs. Pacira BioSciences, | Intracellular vs. Collegium Pharmaceutical |
| Esperion Therapeutics vs. Bausch Health Companies | Esperion Therapeutics vs. Haleon plc | Esperion Therapeutics vs. Intracellular Th |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |